MarketInOut Stock Screener Log In | Sign Up

ADMA Biologics Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/30/2026
ADMA Biologics Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization2,555.67 mln
Float214 mln
Earnings Date11/04/2026

EPS

0.70
Moderate

P / E

16.30
Moderately valued

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.37
Borderline

Relative Strength

88 / 100
Strongly outperforming

Debt / Equity

0.50
Moderate leverage

Business Description

ADMA Biologics is a U.S.-based company that produces and sells medicines made from human plasma, primarily used to help patients with weakened immune systems or serious infections like Hepatitis B. Founded in 2004 and based in Ramsey, New Jersey, the company runs its own plasma collection centers and manufacturing operations to support its product line. Its treatments reach patients through wholesalers, specialty pharmacies, and distributors across the United States and in other countries.

Key Fundamentals

EPS0.70
P/E16.30
ROE40.13
RPS2.18
ROIC36.35
ROA27.17
Interest Cover24.53
EBITDA, mln233
EV / EBITDA11.21
EV / EBIT11.59
Revenue, mln512
EV / Revenue5.10

Quote Details

Last 11.41
Change -0.34 (-2.89%)
Open 11.85
Volume 2,460,208
Turnover 28,070,972
Average Volume 2,735,633

Financial Ratios

Pre-Tax Profit Margin42
Leverage Ratio1.68
Current Ratio6.97
Price / Book6.17
Price / Tangible Book6.24
Price / Cash Flow19.05
Price / Free Cash Flow22.88
Debt / Equity0.50
Price / Sales5.21

Financial Strength

Altman Z-Score7.86
Piotroski F-Score 5 / 9
Beneish M-Score-2.37
Price to Intrinsic Value14.32
Price to Graham Number2.08
Short Ratio5.82
Short % of Float10.74

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 6.84% 91 / 100   
1 Month 14.9% 95 / 100   
2 Months 34.55% 96 / 100   
6 Months 8.46% 81 / 100   
1 Year -26.53% 28 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog